'''A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the ...'

'''Bayer HealthCare presented results from a global Phase II study of florbetaben, its imaging agent in development for the detection of cerebral beta-Amyloid plaques, at the 19th World Congress of Neurology (WCN). The purpose of the Phase II study was ...'

'''U.S. regulatory staff, in a memo released on Friday, questioned how well a GE Healthcare experimental imaging drug would help doctors more easily diagnose Parkinsonß's disease and other movement disorders. The company, a unit of General Electric Co ...'